Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...8889909192939495969798...401402»
  • ||||||||||  Journal:  VEGFA Promotes Skeletal Muscle Regeneration in Aging. (Pubmed Central) -  Nov 1, 2023   
    There was a significant interaction between nutrition, step count, and time for skeletal muscle mass (Janssen equation) (p?=?0.022). ML228, a hypoxia signaling activator known to increase VEGFA levels, augments muscle VEGFA levels and increases average CSA of regenerating fibers in both old mice (25% increase, p
  • ||||||||||  Review, Journal:  E-Health Interventions for Older Adults With Frailty: A Systematic Review. (Pubmed Central) -  Oct 31, 2023   
    : This systematic review found insufficient evidence to support the efficacy of e-Health interventions. Nevertheless, the studies included in this review showed positive effects of e-Health interventions on improving muscle strength, physical activity, and quality of life in older adults with frailty.
  • ||||||||||  Review, Journal:  Validated Tools for Screening Sarcopenia: A Scoping Review. (Pubmed Central) -  Oct 30, 2023   
    More than 50 validated tools are currently available for screening sarcopenia in different clinical settings. The results of this review may help clinicians and researchers in selecting optimal tools for sarcopenia in different clinical scenarios and in developing future tools.
  • ||||||||||  Biomarker, Journal:  Development of multiple biomarker panels for prediction of sarcopenia in community-dwelling older adults. (Pubmed Central) -  Oct 30, 2023   
    The Health ABC provides a knowledge base for the prevention of disability and promotion of mobility in older adults. Multi-biomarker risk score, which was a combination of eight biomarkers with different pathophysiologies, better discriminated the presence of sarcopenia than a single biomarker, and it could further predict the incidence of sarcopenia over two years in older adults.
  • ||||||||||  Trial completion date, Trial primary completion date:  CHRONOS-SARC: High-definition Surface Electromyography Markers for the Diagnosis of Sarcopenia (clinicaltrials.gov) -  Oct 30, 2023   
    P=N/A,  N=50, Recruiting, 
    GDF-8 and its binding proteins, follistatin and FSTL-3, may constitute a counterregulatory system (chalones) to restrain age-related loss of muscle mass and strength. Trial completion date: May 2023 --> Jun 2025 | Trial primary completion date: May 2023 --> May 2025
  • ||||||||||  Journal:  Anorexia of aging: An international assessment of healthcare providers' knowledge and practice gaps. (Pubmed Central) -  Oct 28, 2023   
    Findings from this international assessment highlight the challenges in the care of older adults with or at risk for anorexia of aging. Identifying professional practice gaps between individual HCPs and team-based gaps can provide a basis for healthcare education that is addressed at root causes, targeted to specific audiences and developed to improve individual and team practices that contribute to improving patient outcomes.
  • ||||||||||  Biomarker, Journal:  Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma. (Pubmed Central) -  Oct 28, 2023   
    High expression levels of hsa_circ_0003570 (hazard ratio (HR), 0.437; p = 0.009) and hsa_circ_0004018 (HR, 0.435; p = 0.005) were inversely independent risk factors for overall and progression-free survival in patients with HBV-HCC, whereas the combination group was also an inversely independent risk factor for overall (HR, 0.399; p = 0.005) and progression-free survival (HR, 0.422; p = 0.003) in patients with HBV-HCC. The combination of hsa_circ_0003570 and hsa_circ_0004018 may be a potential prognostic biomarker for HBV-HCC.
  • ||||||||||  Journal:  Calsarcin-2 May Play a Compensatory Role in the Development of Obese Sarcopenia. (Pubmed Central) -  Oct 28, 2023   
    Although calsarcin-2 facilitated myoblast differentiation, the serum calsarcin-2 concentration was negatively related to skeletal muscle mass index in mice and human subjects. Taken together, calsarcin-2 might facilitate myoblast differentiation and appear to play a compensatory role in sarcopenia.
  • ||||||||||  Journal, HEOR:  Longitudinal Changes in Physical Function and Their Impact on Health Outcomes in COVID-19 Patients. (Pubmed Central) -  Oct 28, 2023   
    This study highlights the prevalence of reduced physical function among COVID-19 survivors and emphasises the importance of early identification and intervention to optimise their long-term health. Monitoring HGS, a simple and reliable tool, can provide valuable insights into patients' overall physical function, aiding in tailored care and improved outcomes.
  • ||||||||||  Preclinical, Review, Journal:  The Role of Vitamin D in Skeletal Muscle Repair and Regeneration in Animal Models and Humans: A Systematic Review. (Pubmed Central) -  Oct 28, 2023   
    Finally, human studies reported the benefits of vitamin D supplementation and achieving optimal serum vitamin D levels in muscle recovery after eccentric exercise and surgery. However, there were no benefits in rotator cuff injury studies, suggesting that repair mechanisms for muscle/ligament tears may be less reliant on vitamin D. In summary, vitamin D plays a crucial role in skeletal muscle function, structural integrity, and regeneration, potentially offering therapeutic benefits to patients with musculoskeletal diseases and in post-operative recovery.